Tarzena Capsules 0.1mg, manufactured by Pfizer, contains Talazoparib (YJ code: 4291081M1022, standard: 0.1mg 1 capsule). This poly ADP-ribose polymerase (PARP) inhibitor is used to treat advanced breast cancer with germline BRCA mutations and homologous recombination repair (HRR) gene-mutated metastatic castration-resistant prostate cancer, by preventing DNA repair and leading to synthetic lethality in cancer cells.
Tarzena Capsules 0.1mg
Need more detailed information?
Contact TASAKI PHARMA for product sourcing, availability, or related support (English support available).
